 | • レポートコード：GIR-107A12013 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、β2アドレナリン受容体作動薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。β2アドレナリン受容体作動薬の種類別市場規模（アルブテロール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール）、用途別市場規模（気管支喘息、喘息性気管支炎、肺気腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・β2アドレナリン受容体作動薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Ivax Pharmaceuticals 、Physicians Total Care、Baxter Healthcare 、Sanofi、Pfizer、Bedford Laboratories、Novartis、Sterimax、Teligent、AstraZeneca、Hikma Pharmaceuticals、Av Kare、Impax Laboratories、PD-Rx Pharmaceuticals、Athenex Pharmaceutical Division、Teva、Marlex Pharmaceuticals、Lannett Company、West-Ward Pharmaceuticals、United Biomedical、Merck、Mylan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アルブテロール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール ・用途別分析2016年-2026年：気管支喘息、喘息性気管支炎、肺気腫、その他 ・β2アドレナリン受容体作動薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・β2アドレナリン受容体作動薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・β2アドレナリン受容体作動薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・β2アドレナリン受容体作動薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・β2アドレナリン受容体作動薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The β2 Adrenoceptor Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global β2 Adrenoceptor Agonists size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global β2 Adrenoceptor Agonists market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
β2 Adrenoceptor Agonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Albuterol
Terbutaline
Salmeterol
Formoterol
Pirbuterol
Market segment by Application, can be divided into
Bronchial Asthma
Asthmatic Bronchitis
Emphysema
Others
Market segment by players, this report covers
Ivax Pharmaceuticals
Physicians Total Care
Baxter Healthcare
Sanofi
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent
AstraZeneca
Hikma Pharmaceuticals
Av Kare
Impax Laboratories
PD-Rx Pharmaceuticals
Athenex Pharmaceutical Division
Teva
Marlex Pharmaceuticals
Lannett Company
West-Ward Pharmaceuticals
United Biomedical
Merck
Mylan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of β2 Adrenoceptor Agonists
1.2 Classification of β2 Adrenoceptor Agonists by Type
1.2.1 Overview: Global β2 Adrenoceptor Agonists Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global β2 Adrenoceptor Agonists Revenue Market Share by Type in 2020
1.2.3 Albuterol
1.2.4 Terbutaline
1.2.5 Salmeterol
1.2.6 Formoterol
1.2.7 Pirbuterol
1.3 Global β2 Adrenoceptor Agonists Market by Application
1.3.1 Overview: Global β2 Adrenoceptor Agonists Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Bronchial Asthma
1.3.3 Asthmatic Bronchitis
1.3.4 Emphysema
1.3.5 Others
1.4 Global β2 Adrenoceptor Agonists Market Size & Forecast
1.5 Global β2 Adrenoceptor Agonists Market Size and Forecast by Region
1.5.1 Global β2 Adrenoceptor Agonists Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global β2 Adrenoceptor Agonists Market Size by Region, (2016-2021)
1.5.3 North America β2 Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.4 Europe β2 Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific β2 Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.6 South America β2 Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa β2 Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 β2 Adrenoceptor Agonists Market Drivers
1.6.2 β2 Adrenoceptor Agonists Market Restraints
1.6.3 β2 Adrenoceptor Agonists Trends Analysis
2 Company Profiles
2.1 Ivax Pharmaceuticals
2.1.1 Ivax Pharmaceuticals Details
2.1.2 Ivax Pharmaceuticals Major Business
2.1.3 Ivax Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.1.4 Ivax Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Ivax Pharmaceuticals Recent Developments and Future Plans
2.2 Physicians Total Care
2.2.1 Physicians Total Care Details
2.2.2 Physicians Total Care Major Business
2.2.3 Physicians Total Care β2 Adrenoceptor Agonists Product and Solutions
2.2.4 Physicians Total Care β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Physicians Total Care Recent Developments and Future Plans
2.3 Baxter Healthcare
2.3.1 Baxter Healthcare Details
2.3.2 Baxter Healthcare Major Business
2.3.3 Baxter Healthcare β2 Adrenoceptor Agonists Product and Solutions
2.3.4 Baxter Healthcare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Baxter Healthcare Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi β2 Adrenoceptor Agonists Product and Solutions
2.4.4 Sanofi β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer β2 Adrenoceptor Agonists Product and Solutions
2.5.4 Pfizer β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bedford Laboratories
2.6.1 Bedford Laboratories Details
2.6.2 Bedford Laboratories Major Business
2.6.3 Bedford Laboratories β2 Adrenoceptor Agonists Product and Solutions
2.6.4 Bedford Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bedford Laboratories Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis β2 Adrenoceptor Agonists Product and Solutions
2.7.4 Novartis β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Sterimax
2.8.1 Sterimax Details
2.8.2 Sterimax Major Business
2.8.3 Sterimax β2 Adrenoceptor Agonists Product and Solutions
2.8.4 Sterimax β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sterimax Recent Developments and Future Plans
2.9 Teligent
2.9.1 Teligent Details
2.9.2 Teligent Major Business
2.9.3 Teligent β2 Adrenoceptor Agonists Product and Solutions
2.9.4 Teligent β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Teligent Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca β2 Adrenoceptor Agonists Product and Solutions
2.10.4 AstraZeneca β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Hikma Pharmaceuticals
2.11.1 Hikma Pharmaceuticals Details
2.11.2 Hikma Pharmaceuticals Major Business
2.11.3 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.11.4 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.12 Av Kare
2.12.1 Av Kare Details
2.12.2 Av Kare Major Business
2.12.3 Av Kare β2 Adrenoceptor Agonists Product and Solutions
2.12.4 Av Kare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Av Kare Recent Developments and Future Plans
2.13 Impax Laboratories
2.13.1 Impax Laboratories Details
2.13.2 Impax Laboratories Major Business
2.13.3 Impax Laboratories β2 Adrenoceptor Agonists Product and Solutions
2.13.4 Impax Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Impax Laboratories Recent Developments and Future Plans
2.14 PD-Rx Pharmaceuticals
2.14.1 PD-Rx Pharmaceuticals Details
2.14.2 PD-Rx Pharmaceuticals Major Business
2.14.3 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.14.4 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 PD-Rx Pharmaceuticals Recent Developments and Future Plans
2.15 Athenex Pharmaceutical Division
2.15.1 Athenex Pharmaceutical Division Details
2.15.2 Athenex Pharmaceutical Division Major Business
2.15.3 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Product and Solutions
2.15.4 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Athenex Pharmaceutical Division Recent Developments and Future Plans
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva β2 Adrenoceptor Agonists Product and Solutions
2.16.4 Teva β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Teva Recent Developments and Future Plans
2.17 Marlex Pharmaceuticals
2.17.1 Marlex Pharmaceuticals Details
2.17.2 Marlex Pharmaceuticals Major Business
2.17.3 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.17.4 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Marlex Pharmaceuticals Recent Developments and Future Plans
2.18 Lannett Company
2.18.1 Lannett Company Details
2.18.2 Lannett Company Major Business
2.18.3 Lannett Company β2 Adrenoceptor Agonists Product and Solutions
2.18.4 Lannett Company β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Lannett Company Recent Developments and Future Plans
2.19 West-Ward Pharmaceuticals
2.19.1 West-Ward Pharmaceuticals Details
2.19.2 West-Ward Pharmaceuticals Major Business
2.19.3 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.19.4 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 West-Ward Pharmaceuticals Recent Developments and Future Plans
2.20 United Biomedical
2.20.1 United Biomedical Details
2.20.2 United Biomedical Major Business
2.20.3 United Biomedical β2 Adrenoceptor Agonists Product and Solutions
2.20.4 United Biomedical β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 United Biomedical Recent Developments and Future Plans
2.21 Merck
2.21.1 Merck Details
2.21.2 Merck Major Business
2.21.3 Merck β2 Adrenoceptor Agonists Product and Solutions
2.21.4 Merck β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Merck Recent Developments and Future Plans
2.22 Mylan
2.22.1 Mylan Details
2.22.2 Mylan Major Business
2.22.3 Mylan β2 Adrenoceptor Agonists Product and Solutions
2.22.4 Mylan β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global β2 Adrenoceptor Agonists Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 β2 Adrenoceptor Agonists Players Market Share
3.2.2 Top 10 β2 Adrenoceptor Agonists Players Market Share
3.2.3 Market Competition Trend
3.3 β2 Adrenoceptor Agonists Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global β2 Adrenoceptor Agonists Revenue and Market Share by Type (2016-2021)
4.2 Global β2 Adrenoceptor Agonists Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2016-2021)
5.2 β2 Adrenoceptor Agonists Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America β2 Adrenoceptor Agonists Revenue by Type (2016-2026)
6.2 North America β2 Adrenoceptor Agonists Revenue by Application (2016-2026)
6.3 North America β2 Adrenoceptor Agonists Market Size by Country
6.3.1 North America β2 Adrenoceptor Agonists Revenue by Country (2016-2026)
6.3.2 United States β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
6.3.3 Canada β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
6.3.4 Mexico β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe β2 Adrenoceptor Agonists Revenue by Type (2016-2026)
7.2 Europe β2 Adrenoceptor Agonists Revenue by Application (2016-2026)
7.3 Europe β2 Adrenoceptor Agonists Market Size by Country
7.3.1 Europe β2 Adrenoceptor Agonists Revenue by Country (2016-2026)
7.3.2 Germany β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.3 France β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.4 United Kingdom β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.5 Russia β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.6 Italy β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Type (2016-2026)
8.2 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Application (2016-2026)
8.3 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region
8.3.1 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Region (2016-2026)
8.3.2 China β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.3 Japan β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.4 South Korea β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.5 India β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.7 Australia β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America β2 Adrenoceptor Agonists Revenue by Type (2016-2026)
9.2 South America β2 Adrenoceptor Agonists Revenue by Application (2016-2026)
9.3 South America β2 Adrenoceptor Agonists Market Size by Country
9.3.1 South America β2 Adrenoceptor Agonists Revenue by Country (2016-2026)
9.3.2 Brazil β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
9.3.3 Argentina β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa β2 Adrenoceptor Agonists Revenue by Type (2016-2026)
10.2 Middle East & Africa β2 Adrenoceptor Agonists Revenue by Application (2016-2026)
10.3 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country
10.3.1 Middle East & Africa β2 Adrenoceptor Agonists Revenue by Country (2016-2026)
10.3.2 Turkey β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
10.3.4 UAE β2 Adrenoceptor Agonists Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global β2 Adrenoceptor Agonists Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global β2 Adrenoceptor Agonists Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market β2 Adrenoceptor Agonists Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global β2 Adrenoceptor Agonists Revenue (USD Million) by Region (2016-2021)
Table 5. Global β2 Adrenoceptor Agonists Revenue Market Share by Region (2021-2026)
Table 6. Ivax Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Ivax Pharmaceuticals Major Business
Table 8. Ivax Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 9. Ivax Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Physicians Total Care Corporate Information, Head Office, and Major Competitors
Table 11. Physicians Total Care Major Business
Table 12. Physicians Total Care β2 Adrenoceptor Agonists Product and Solutions
Table 13. Physicians Total Care β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Baxter Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. Baxter Healthcare Major Business
Table 16. Baxter Healthcare β2 Adrenoceptor Agonists Product and Solutions
Table 17. Baxter Healthcare β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi β2 Adrenoceptor Agonists Product and Solutions
Table 21. Sanofi β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer β2 Adrenoceptor Agonists Product and Solutions
Table 25. Pfizer β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bedford Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bedford Laboratories Major Business
Table 28. Bedford Laboratories β2 Adrenoceptor Agonists Product and Solutions
Table 29. Bedford Laboratories β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis β2 Adrenoceptor Agonists Product and Solutions
Table 33. Novartis β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sterimax Corporate Information, Head Office, and Major Competitors
Table 35. Sterimax Major Business
Table 36. Sterimax β2 Adrenoceptor Agonists Product and Solutions
Table 37. Sterimax β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Teligent Corporate Information, Head Office, and Major Competitors
Table 39. Teligent Major Business
Table 40. Teligent β2 Adrenoceptor Agonists Product and Solutions
Table 41. Teligent β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 43. AstraZeneca Major Business
Table 44. AstraZeneca β2 Adrenoceptor Agonists Product and Solutions
Table 45. AstraZeneca β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Hikma Pharmaceuticals Major Business
Table 48. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 49. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Av Kare Corporate Information, Head Office, and Major Competitors
Table 51. Av Kare Major Business
Table 52. Av Kare β2 Adrenoceptor Agonists Product and Solutions
Table 53. Av Kare β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Impax Laboratories Corporate Information, Head Office, and Major Competitors
Table 55. Impax Laboratories Major Business
Table 56. Impax Laboratories β2 Adrenoceptor Agonists Product and Solutions
Table 57. Impax Laboratories β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. PD-Rx Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. PD-Rx Pharmaceuticals Major Business
Table 60. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 61. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Athenex Pharmaceutical Division Corporate Information, Head Office, and Major Competitors
Table 63. Athenex Pharmaceutical Division Major Business
Table 64. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Product and Solutions
Table 65. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Teva Corporate Information, Head Office, and Major Competitors
Table 67. Teva Major Business
Table 68. Teva β2 Adrenoceptor Agonists Product and Solutions
Table 69. Teva β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Marlex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 71. Marlex Pharmaceuticals Major Business
Table 72. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 73. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Lannett Company Corporate Information, Head Office, and Major Competitors
Table 75. Lannett Company Major Business
Table 76. Lannett Company β2 Adrenoceptor Agonists Product and Solutions
Table 77. Lannett Company β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. West-Ward Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 79. West-Ward Pharmaceuticals Major Business
Table 80. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 81. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. United Biomedical Corporate Information, Head Office, and Major Competitors
Table 83. United Biomedical Major Business
Table 84. United Biomedical β2 Adrenoceptor Agonists Product and Solutions
Table 85. United Biomedical β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Merck Corporate Information, Head Office, and Major Competitors
Table 87. Merck Major Business
Table 88. Merck β2 Adrenoceptor Agonists Product and Solutions
Table 89. Merck β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Mylan Corporate Information, Head Office, and Major Competitors
Table 91. Mylan Major Business
Table 92. Mylan β2 Adrenoceptor Agonists Product and Solutions
Table 93. Mylan β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Global β2 Adrenoceptor Agonists Revenue (USD Million) by Players (2019-2021)
Table 95. Global β2 Adrenoceptor Agonists Revenue Share by Players (2019-2021)
Table 96. Breakdown of β2 Adrenoceptor Agonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. β2 Adrenoceptor Agonists Players Head Office, Products and Services Provided
Table 98. β2 Adrenoceptor Agonists Mergers & Acquisitions in the Past Five Years
Table 99. β2 Adrenoceptor Agonists New Entrants and Expansion Plans
Table 100. Global β2 Adrenoceptor Agonists Revenue (USD Million) by Type (2016-2021)
Table 101. Global β2 Adrenoceptor Agonists Revenue Share by Type (2016-2021)
Table 102. Global β2 Adrenoceptor Agonists Revenue Forecast by Type (2021-2026)
Table 103. Global β2 Adrenoceptor Agonists Revenue by Application (2016-2021)
Table 104. Global β2 Adrenoceptor Agonists Revenue Forecast by Application (2021-2026)
Table 105. North America β2 Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 106. North America β2 Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 107. North America β2 Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 108. North America β2 Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 109. North America β2 Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 110. North America β2 Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
Table 111. Europe β2 Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 112. Europe β2 Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 113. Europe β2 Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 114. Europe β2 Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 115. Europe β2 Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 116. Europe β2 Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
Table 117. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 118. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 119. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 120. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 121. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Region (2016-2021) & (USD Million)
Table 122. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Region (2021-2026) & (USD Million)
Table 123. South America β2 Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 124. South America β2 Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 125. South America β2 Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 126. South America β2 Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 127. South America β2 Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 128. South America β2 Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 130. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 131. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 132. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 133. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 134. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. β2 Adrenoceptor Agonists Picture
Figure 2. Global β2 Adrenoceptor Agonists Revenue Market Share by Type in 2020
Figure 3. Albuterol
Figure 4. Terbutaline
Figure 5. Salmeterol
Figure 6. Formoterol
Figure 7. Pirbuterol
Figure 8. β2 Adrenoceptor Agonists Revenue Market Share by Application in 2020
Figure 9. Bronchial Asthma Picture
Figure 10. Asthmatic Bronchitis Picture
Figure 11. Emphysema Picture
Figure 12. Others Picture
Figure 13. Global β2 Adrenoceptor Agonists Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global β2 Adrenoceptor Agonists Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global β2 Adrenoceptor Agonists Revenue Market Share by Region (2016-2026)
Figure 16. Global β2 Adrenoceptor Agonists Revenue Market Share by Region in 2020
Figure 17. North America β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. β2 Adrenoceptor Agonists Market Drivers
Figure 23. β2 Adrenoceptor Agonists Market Restraints
Figure 24. β2 Adrenoceptor Agonists Market Trends
Figure 25. Ivax Pharmaceuticals Recent Developments and Future Plans
Figure 26. Physicians Total Care Recent Developments and Future Plans
Figure 27. Baxter Healthcare Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Bedford Laboratories Recent Developments and Future Plans
Figure 31. Novartis Recent Developments and Future Plans
Figure 32. Sterimax Recent Developments and Future Plans
Figure 33. Teligent Recent Developments and Future Plans
Figure 34. AstraZeneca Recent Developments and Future Plans
Figure 35. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 36. Av Kare Recent Developments and Future Plans
Figure 37. Impax Laboratories Recent Developments and Future Plans
Figure 38. PD-Rx Pharmaceuticals Recent Developments and Future Plans
Figure 39. Athenex Pharmaceutical Division Recent Developments and Future Plans
Figure 40. Teva Recent Developments and Future Plans
Figure 41. Marlex Pharmaceuticals Recent Developments and Future Plans
Figure 42. Lannett Company Recent Developments and Future Plans
Figure 43. West-Ward Pharmaceuticals Recent Developments and Future Plans
Figure 44. United Biomedical Recent Developments and Future Plans
Figure 45. Merck Recent Developments and Future Plans
Figure 46. Mylan Recent Developments and Future Plans
Figure 47. Global β2 Adrenoceptor Agonists Revenue Share by Players in 2020
Figure 48. β2 Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 49. Global Top 3 Players β2 Adrenoceptor Agonists Revenue Market Share in 2020
Figure 50. Global Top 10 Players β2 Adrenoceptor Agonists Revenue Market Share in 2020
Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 52. Global β2 Adrenoceptor Agonists Revenue Share by Type in 2020
Figure 53. Global β2 Adrenoceptor Agonists Market Share Forecast by Type (2021-2026)
Figure 54. Global β2 Adrenoceptor Agonists Revenue Share by Application in 2020
Figure 55. Global β2 Adrenoceptor Agonists Market Share Forecast by Application (2021-2026)
Figure 56. North America β2 Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 57. North America β2 Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 58. North America β2 Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 59. United States β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Canada β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Mexico β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Europe β2 Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 63. Europe β2 Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 64. Europe β2 Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 65. Germany β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. France β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. United Kingdom β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Russia β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Italy β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Asia-Pacific β2 Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 71. Asia-Pacific β2 Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 72. Asia-Pacific β2 Adrenoceptor Agonists Revenue Market Share by Region (2016-2026)
Figure 73. China β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Japan β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Korea β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. India β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Southeast Asia β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Australia β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South America β2 Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 80. South America β2 Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 81. South America β2 Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 82. Brazil β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Argentina β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Middle East and Africa β2 Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 85. Middle East and Africa β2 Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 86. Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 87. Turkey β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Saudi Arabia β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. UAE β2 Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Methodology
Figure 91. Research Process and Data Source
世界のβ1アドレナリン受容体作動薬市場 2021：企業別、地域別、種類・用途別 The β1 Adrenoceptor Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界のβアドレナリン受容体作動薬市場 2021：企業別、地域別、種類・用途別 The β Adrenoceptor Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の非選択的アゴニスト市場 2021：企業別、地域別、種類・用途別 The Nonselective Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の選択的アゴニスト市場 2021：企業別、地域別、種類・用途別 The Selective Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の緑内障点眼薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Eye drops used in managing glaucoma decrease eye pressure by helping the eye’s fluid to drain better andor decreasing the amount of fluid made by the eye. Scope of the Report: The worldwide market for Glaucoma Eye Drops is expected to grow at a CAGR of roughly xx% over the next five years, will reac…